<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dewey M</submitter><funding>Intramural NIH HHS</funding><funding>Canon Medical Systems Corporation Tokyo CL Square</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Institutes of Health</funding><pagination>485-491</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8570979</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Few data exist on long-term outcome in patients undergoing combined coronary CT angiography (CTA) and myocardial CT perfusion imaging (CTP) as well as invasive coronary angiography (ICA) and single photon emission tomography (SPECT).&lt;h4>Methods&lt;/h4>At 16 centers, 381 patients were followed for major adverse cardiac events (MACE) for the CORE320 study. All patients underwent coronary CTA, CTP, and SPECT before ICA within 60 days. Prognostic performance according binary results (normal/abnormal) was assessed by 5-year major cardiovascular events (MACE) free survival and area under the receiver-operating-characteristic curve (AUC).&lt;h4>Results&lt;/h4>Follow up beyond 2-years was available in 323 patients. MACE-free survival rate was greater among patients with normal combined C</pubmed_abstract><journal>Journal of cardiovascular computed tomography</journal><pubmed_title>Prognostic value of noninvasive combined anatomic/functional assessment by cardiac CT in patients with suspected coronary artery disease - Comparison with invasive coronary angiography and nuclear myocardial perfusion imaging for the five-year-follow up of the CORE320 multicenter study.</pubmed_title><pmcid>PMC8570979</pmcid><funding_grant_id>ZIA HL006138</funding_grant_id><funding_grant_id>ZIA HL006220</funding_grant_id><pubmed_authors>Ostovaneh MR</pubmed_authors><pubmed_authors>Vavere AL</pubmed_authors><pubmed_authors>George RT</pubmed_authors><pubmed_authors>Tan SY</pubmed_authors><pubmed_authors>Paul N</pubmed_authors><pubmed_authors>Cerci R</pubmed_authors><pubmed_authors>Niinuma H</pubmed_authors><pubmed_authors>Nomura C</pubmed_authors><pubmed_authors>Lima JAC</pubmed_authors><pubmed_authors>Kitagawa K</pubmed_authors><pubmed_authors>Laham R</pubmed_authors><pubmed_authors>Di Carli M</pubmed_authors><pubmed_authors>Matheson MB</pubmed_authors><pubmed_authors>Rochitte CE</pubmed_authors><pubmed_authors>Hoe J</pubmed_authors><pubmed_authors>Chen MY</pubmed_authors><pubmed_authors>Laule M</pubmed_authors><pubmed_authors>Jinzaki M</pubmed_authors><pubmed_authors>Arbab-Zadeh A</pubmed_authors><pubmed_authors>Dewey M</pubmed_authors><pubmed_authors>Cox C</pubmed_authors><pubmed_authors>Sakuma H</pubmed_authors><pubmed_authors>Yoshioka K</pubmed_authors><pubmed_authors>Brinker J</pubmed_authors><pubmed_authors>Arai AE</pubmed_authors><pubmed_authors>Kofoed K</pubmed_authors><pubmed_authors>Clouse ME</pubmed_authors><pubmed_authors>Kuribayashi S</pubmed_authors><pubmed_authors>Scholte AJ</pubmed_authors><pubmed_authors>Mehra VC</pubmed_authors><pubmed_authors>Rybicki FJ</pubmed_authors><pubmed_authors>Miller JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic value of noninvasive combined anatomic/functional assessment by cardiac CT in patients with suspected coronary artery disease - Comparison with invasive coronary angiography and nuclear myocardial perfusion imaging for the five-year-follow up of the CORE320 multicenter study.</name><description>&lt;h4>Background&lt;/h4>Few data exist on long-term outcome in patients undergoing combined coronary CT angiography (CTA) and myocardial CT perfusion imaging (CTP) as well as invasive coronary angiography (ICA) and single photon emission tomography (SPECT).&lt;h4>Methods&lt;/h4>At 16 centers, 381 patients were followed for major adverse cardiac events (MACE) for the CORE320 study. All patients underwent coronary CTA, CTP, and SPECT before ICA within 60 days. Prognostic performance according binary results (normal/abnormal) was assessed by 5-year major cardiovascular events (MACE) free survival and area under the receiver-operating-characteristic curve (AUC).&lt;h4>Results&lt;/h4>Follow up beyond 2-years was available in 323 patients. MACE-free survival rate was greater among patients with normal combined C</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov-Dec</publication><modification>2025-04-04T22:33:42.176Z</modification><creation>2025-02-19T03:23:57.897Z</creation></dates><accession>S-EPMC8570979</accession><cross_references><pubmed>34024757</pubmed><doi>10.1016/j.jcct.2021.04.005</doi></cross_references></HashMap>